1 ectious cDNA clone of a genotype 3 strain of
hepatitis E virus adapted to growth in HepG2/C3A human h
2 We test the infections of two RNA viruses,
hepatitis E virus and SARS-CoV-2, and one DNA virus, mon
3 elm mottle virus, in animal viruses like the
hepatitis E virus and the caprine encephalitis virus, an
4 ted in 75 of 108 (69%) patients, antibody to
hepatitis E virus (
anti-HEV) in three patients (3%), and
5 To evaluate antibody to
hepatitis E virus (
anti-HEV) seroreactivity, 5000 US blo
6 Baseline prevalence of antibody to
hepatitis E virus (
anti-HEV) was 22.5%.
7 tibodies to hepatitis A virus (anti-HAV) and
hepatitis E virus (
anti-HEV) was 65.2% (95% CI, 64.2%-66
8 mance of existing assays for antibody to the
hepatitis E virus (
anti-HEV).
9 If the occurrence of
hepatitis E virus antibody (anti-HEV) in regions where t
10 haracterized a novel virus, designated avian
hepatitis E virus (
avian HEV), from chickens with hepati
11 ulation: human T-cell leukemia virus type 1;
hepatitis E virus;
bocavirus; KI and WU polyomaviruses;
12 Based on a
hepatitis E virus capsid model, we performed homology mo
13 a-barrel structure that is also found in the
hepatitis E virus capsid protrusions, suggesting a close
14 owever, recent work on hepatitis A virus and
hepatitis E virus challenges this long-held tenet.
15 , the ICTV approved a proposal to remove the
hepatitis E virus from the Caliciviridae into an "unassi
16 Hepatitis E virus genotype 1 strain Sar55 replicated in
17 Indigenous, foodborne transmission of
hepatitis E virus genotype 3 (HEV G3) has become recogni
18 that sofosbuvir inhibits the replication of
hepatitis E virus genotype 3 both in subgenomic replicon
19 Infection with
hepatitis E virus genotype 3 may result in chronic hepat
20 Hepatitis E virus has been reported to result in chronic
21 association between serum antibodies against
hepatitis E virus (
HEV) and central nervous system (CNS)
22 odies against the emerging zoonotic pathogen
hepatitis E virus (
HEV) and enteropathogenic Yersinia sp
23 The thermal stability of virulent
hepatitis E virus (
HEV) and hepatitis A virus (HAV) was
24 he host responses to two dissimilar viruses,
hepatitis E virus (
HEV) and hepatitis C virus (HCV), wer
25 s have shown a relatively high prevalence of
hepatitis E virus (
HEV) antibody.
26 Hepatitis E virus (
HEV) can chronically infect immunocom
27 -strands similar to what was observed in the
hepatitis E virus (
HEV) capsid structure.
28 Hepatitis E virus (
HEV) causes both endemic and epidemic
29 Hepatitis E virus (
HEV) causes outbreaks of jaundice ass
30 Hepatitis E virus (
HEV) causes roughly 20 million yearly
31 Hepatitis E virus (
HEV) constitutes a substantial public
32 The RNA genome of the
hepatitis E virus (
HEV) contains a hypervariable region
33 ntigen derived from the Meng strain of swine
hepatitis E virus (
HEV) differs from that of the Sar-55
34 All patients cleared the
hepatitis E virus (
HEV) except for 2 (nonresponders); 1
35 tment options for patients who fail to clear
hepatitis E virus (
HEV) following reduction of immunosup
36 Hepatitis E Virus (
HEV) genome encodes three proteins in
37 L) structure in the intergenic region of the
hepatitis E virus (
HEV) genome in virus replication were
38 Hepatitis E virus (
HEV) genotype 1 (HEV-1) infection in
39 Hepatitis E virus (
HEV) genotype 3 infections are freque
40 The prevalence of
hepatitis E virus (
HEV) genotype 3 infections in the Eng
41 ports of food-borne zoonotic transmission of
hepatitis E virus (
HEV) genotype 3, which causes chronic
42 We estimated the global burden of
hepatitis E virus (
HEV) genotypes 1 and 2 in 2005.
43 Hepatitis E virus (
HEV) has been recognized as a threat
44 Hepatitis E virus (
HEV) has emerged as a cause of chroni
45 Hepatitis E virus (
HEV) has recently been cloned and seq
46 Moreover, a high prevalence (17%) of
hepatitis E virus (
HEV) immunoglobulin G antibodies (ant
47 eriod, 38 of 48 persons testing positive for
hepatitis E virus (
HEV) immunoglobulin M in Los Angeles
48 sceptible humans may serve as a reservoir of
hepatitis E virus (
HEV) in areas in which HEV is endemic
49 ce and molecular characterisation studies of
hepatitis E virus (
HEV) in England and Wales have been u
50 The recent identification of antibody to
hepatitis E virus (
HEV) in pigs, sheep, and cattle and c
51 amination and evaluate the dispersion of the
hepatitis E virus (
HEV) in the environment.
52 The awareness of
hepatitis E virus (
HEV) increased significantly in the l
53 Hepatitis E virus (
HEV) induces acute hepatitis in human
54 Transplant recipients are at risk of
hepatitis E virus (
HEV) infection and could be vulnerabl
55 rin is highly efficient for treating chronic
hepatitis E virus (
HEV) infection and shows that HEV RNA
56 However,
hepatitis E virus (
HEV) infection can also be acquired i
57 Hepatitis E virus (
HEV) infection causes major epidemics
58 ntiviral immunity and immunopathology during
hepatitis E virus (
HEV) infection determines important c
59 Hepatitis E virus (
HEV) infection has been proposed as a
60 ical and laboratory features, and outcome of
hepatitis E virus (
HEV) infection in children.
61 Hepatitis E virus (
HEV) infection in pregnant women has
62 nd a relatively high seroprevalence (21%) of
hepatitis E virus (
HEV) infection in the U.S. general po
63 Acute
hepatitis E virus (
HEV) infection is a leading cause of
64 BACKGROUND & AIMS:
Hepatitis E virus (
HEV) infection is a major cause of ac
65 Chronic
hepatitis E virus (
HEV) infection is a significant clini
66 Hepatitis E virus (
HEV) infection is an emerging disease
67 Persistent
hepatitis E virus (
HEV) infection is described in a numb
68 Hepatitis E virus (
HEV) infection is increasingly being
69 Hepatitis E virus (
HEV) infection is the leading cause o
70 Hepatitis E virus (
HEV) infection is usually self-limite
71 Secondary spread of
hepatitis E virus (
HEV) infection occurs often in endemi
72 nsitivity to exogenous type I IFN.IMPORTANCE
Hepatitis E virus (
HEV) infection typically causes self-
73 Hepatitis E virus (
HEV) infection usually results in a s
74 protective efficacy of a DNA vaccine against
hepatitis E virus (
HEV) infection was tested in cynomolg
75 Prevalence of antibody and risk factors to
hepatitis E virus (
HEV) infection were determined in a c
76 s currently recommended for treating chronic
hepatitis E virus (
HEV) infection.
77 There is no established therapy for
hepatitis E virus (
HEV) infection.
78 Hepatitis E virus (
HEV) infections are a major cause of
79 Antiviral treatment options for chronic
Hepatitis E Virus (
HEV) infections are limited and immun
80 Hepatitis E virus (
HEV) infections are one of the most c
81 Among
hepatitis E virus (
HEV) infections diagnosed in 2011 by
82 Transfusion-transmitted
hepatitis E virus (
HEV) infections have raised many conc
83 lid-organ-transplant recipients with chronic
hepatitis E virus (
HEV) infections were given ribavirin
84 There is little knowledge about how
hepatitis E virus (
HEV) inhibits induction of host IFNs,
85 Hepatitis E virus (
HEV) is a 7.2-kb positive-sense, sing
86 Hepatitis E virus (
HEV) is a causative agent of acute he
87 Hepatitis E virus (
HEV) is a human pathogen that causes
88 Hepatitis E virus (
HEV) is a long-neglected RNA virus an
89 Hepatitis E virus (
HEV) is a major cause of acute hepati
90 Hepatitis E virus (
HEV) is a major cause of acute hepati
91 Hepatitis E virus (
HEV) is a major cause of acute viral
92 Hepatitis E virus (
HEV) is a major public health concern
93 The ORF3 protein of
hepatitis E virus (
HEV) is a multifunctional protein imp
94 Hepatitis E virus (
HEV) is a new causative agent of chro
95 Hepatitis E virus (
HEV) is a single-strand positive-sens
96 Hepatitis E virus (
HEV) is a worldwide zoonotic and publ
97 The
hepatitis E virus (
HEV) is an emergent zoonotic virus ca
98 Hepatitis E virus (
HEV) is an emerging virus causing epi
99 complex mechanisms of HEV biology.IMPORTANCE
Hepatitis E virus (
HEV) is an emerging virus found predo
100 Hepatitis E virus (
HEV) is an important but extremely un
101 Hepatitis E virus (
HEV) is an important but extremely un
102 Hepatitis E virus (
HEV) is an important but understudied
103 Hepatitis E virus (
HEV) is an important cause of enteric
104 Hepatitis E virus (
HEV) is an important human pathogen,
105 Hepatitis E virus (
HEV) is an important human pathogen.
106 Hepatitis E virus (
HEV) is an important public health co
107 Hepatitis E virus (
HEV) is an RNA virus responsible for
108 Hepatitis E virus (
HEV) is an unclassified virus with a
109 Hepatitis E virus (
HEV) is believed to be transmitted by
110 Exposure to
hepatitis E virus (
HEV) is common in the United States,
111 Hepatitis E virus (
HEV) is considered a zoonotic infecti
112 Hepatitis E virus (
HEV) is endemic in many developing an
113 Hepatitis E virus (
HEV) is endemic in many resource-poor
114 Hepatitis E virus (
HEV) is increasingly acknowledged as
115 ferent hosts in genotypes 3 and 4.IMPORTANCE
Hepatitis E virus (
HEV) is increasingly recognized as a
116 Hepatitis E virus (
HEV) is one of the most common causes
117 Hepatitis E virus (
HEV) is prevalent and causes disease
118 Although
hepatitis E virus (
HEV) is regarded as a self-limiting i
119 Hepatitis E virus (
HEV) is the causative agent of hepati
120 Hepatitis E virus (
HEV) is the causative agent of hepati
121 Hepatitis E virus (
HEV) is the causative agent of hepati
122 Hepatitis E virus (
HEV) is the leading cause of enterica
123 Avian
hepatitis E virus (
HEV) is the main causative agent of b
124 Hepatitis E virus (
HEV) is the major cause of entericall
125 Hepatitis E virus (
HEV) is the most common cause of acut
126 Hepatitis E virus (
HEV) is the most common cause of acut
127 Hepatitis E virus (
HEV) is the most common cause of acut
128 The RNA virus,
hepatitis E virus (
HEV) is the most or second-most impor
129 Hepatitis E virus (
HEV) is yearly responsible for approx
130 Hepatitis E virus (
HEV) lacks approved virus-specific an
131 Hepatitis E virus (
HEV) leads to high mortality in pregn
132 To determine the initiation strategy of the
hepatitis E virus (
HEV) open reading frame 3 (ORF3), we
133 The
hepatitis E virus (
HEV) polyproline region (PPR) is an i
134 As a positive-strand RNA virus,
hepatitis E virus (
HEV) produces an intermediate negativ
135 urther, we show that enterically transmitted
hepatitis E virus (
HEV) progeny particles are secreted b
136 The antigenic composition of the
hepatitis E virus (
HEV) protein encoded by open reading
137 Hepatitis E virus (
HEV) recently has been shown to be an
138 Hepatitis E virus (
HEV) replication is not well understo
139 The mechanism of
hepatitis E virus (
HEV) replication remains largely unkn
140 The
hepatitis E virus (
HEV) RNA concentrations were determin
141 Hepatitis E virus (
HEV) RNA replication occurred in seve
142 Hepatitis E virus (
HEV) seroprevalences of 0.3%-53% were
143 Here, we report that the macro domain from
hepatitis E virus (
HEV) serves as an ADP-ribose-protein
144 The
hepatitis E virus (
HEV) sheds into feces as nonenveloped
145 The classification of
hepatitis E virus (
HEV) variants is currently in transit
146 with HUE (58.3%) and the pooled library, and
hepatitis E virus (
HEV) was detected in 2 individuals wi
147 nst the ORF2 protein of the SAR-55 strain of
hepatitis E virus (
HEV) were isolated by phage display f
148 onstitutes an attractive control measure for
hepatitis E virus (
HEV), a major cause of maternal and p
149 Avian
hepatitis E virus (
HEV), a novel virus identified from c
150 Hepatitis E virus (
HEV), a single-stranded positive-sens
151 Hepatitis E virus (
HEV), a small, non-enveloped RNA viru
152 Hepatitis E virus (
HEV), an emerging zoonotic pathogen a
153 Hepatitis E virus (
HEV), an enterically transmitted RNA
154 ut how broadly enzootic its causative agent,
hepatitis E virus (
HEV), is remains controversial.
155 Hepatitis E virus (
HEV), rotavirus (RV), and astrovirus
156 Hepatitis E virus (
HEV), the causative agent of hepatiti
157 The effects of
hepatitis E virus (
HEV), the causative agent of hepatiti
158 immunocompromised individuals infected with
hepatitis E virus (
HEV)-g3.
159 s a striking resemblance to the structure of
hepatitis E virus (
HEV)-like particles, as previously pr
160 tudy of Hecolin(R), the licensed vaccine for
hepatitis E virus (
HEV).
161 Hepatitis E virus (
HEV; family Hepeviridae) infections c
162 en-free pigs were inoculated with one of two
hepatitis E viruses (
HEV) (one recovered from a pig and
163 itis-B virus (HBV), hepatitis-C virus (HCV),
hepatitis-E virus (
HEV), dengue virus (DENV), and West N
164 gical and molecular techniques (detection of
hepatitis E virus [
HEV] RNA from stool and serum samples
165 Genotype 1
hepatitis E viruses (
HEVs) are restricted to primate hos
166 Hepatitis E virus IgM and IgG reactivity was determined.
167 Hepatitis E virus IgM and IgG reactivity.
168 The seroprevalence of antibody to
hepatitis E virus in this population was 13.6%; to Barto
169 ral blood and liver tissue revealed an acute
hepatitis E virus infection (genotype 3).
170 Hepatitis E virus infection (HEV) is an emerging problem
171 Hepatitis E virus infection causes an acute hepatitis wi
172 Ribavirin is efficient at treating chronic
hepatitis E virus infection in solid-organ transplant pa
173 ts with a solid-organ transplant and chronic
hepatitis E virus infection were given ribavirin for 3 m
174 ures of inflammatory cell death triggered by
hepatitis E virus infection when integrated with pro-inf
175 Chronic
hepatitis E virus infection with rapid progression to ci
176 Hepatitis E virus is a nonenveloped RNA virus.
177 Hepatitis E Virus-
like particles self-assemble in to non
178 rpes simplex virus-1/2, human herpesvirus 8,
hepatitis E virus,
parvovirus B19).
179 Hepatitis E virus recombinant genomes transcribed in vit
180 We also recruited non-
hepatitis E virus-
related pregnant (P), ALF-NE (n = 5) a
181 ct the multifunctional role of human bile on
hepatitis E virus replication and the inflammatory respo
182 Hepatitis E virus replicons containing the neomycin resi
183 Hepatitis E virus RNA levels also remained detectable in
184 related to the P1 domain in calicivirus and
hepatitis E virus,
suggesting a possible evolutionary re
185 Prior to the recent discovery of the swine
hepatitis E virus (
swine HEV) in pigs from the midwester
186 Swine
hepatitis E virus (
swine HEV), the first animal strain o
187 A novel virus, designated swine
hepatitis E virus (
swine HEV), was identified in pigs.
188 In the case of
hepatitis E virus,
the adjacent viral helicase domain dr
189 ul new tool in the prevention and control of
hepatitis E virus transmission and disease.
190 ablishing the safety and immunogenicity of a
hepatitis E virus vaccine in multiple populations could
191 ly efficiently transfected and infected with
hepatitis E virus was identified.
192 An infectious cDNA clone of
hepatitis E virus was mutated in order to prevent synthe